Phase II trial of temozolomide in children with recurrent high-grade glioma.
Ruggiero A, Cefalo G, Garré ML, Massimino M, Colosimo C, Attinà G, Lazzareschi I, Maurizi P, Ridola V, Mazzarella G, Caldarelli M, Di Rocco C, Madon E, Abate ME, Clerico A, Sandri A, Riccardi R.
Ruggiero A, et al.
J Neurooncol. 2006 Mar;77(1):89-94. doi: 10.1007/s11060-005-9011-2.
J Neurooncol. 2006.
PMID: 16292488
Clinical Trial.